Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Episode 8 - Use of Anti-hyperglycemic Agents with CVD Benefits

    Episode 8 - Use of Anti-hyperglycemic Agents with CVD Benefits

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    Start listeningView podcast show

    Episode 8 - Use of Anti-hyperglycemic Agents with CVD Benefits

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    ratings:
    Length:
    31 minutes
    Released:
    Jul 25, 2019
    Format:
    Podcast episode

    Description

    The management of type 2 diabetes to prevent cardiovascular disease has been focused on glycemic control and the use of drugs based on their ability to lower levels of glycemia. Listen to Dr. Robert Eckel and Dr. Chris Cannon discuss the use of anti-hyperglycemic agents with CVD benefits.
    Released:
    Jul 25, 2019
    Format:
    Podcast episode

    Titles in the series (32)

    The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The American Heart Association’s and the American Diabetes Association's Know Diabetes by Heart Professional Education™ Podcast Series is brought to you by founding sponsors, Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsors, Sanofi, AstraZeneca, and Bayer.